PIVKA-II showed a better accuracy than AFP in the early diagnosis of recurrent HCC (AUC 0.883; 95% CI 0.835–0.931 vs. 0.672; 95% CI 0.596–0.748, p < 0.0001) (Fig. 5). The gene discussed is AFP; the disease is hepatocellular carcinoma.